Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 25;11(3):315.
doi: 10.3390/antibiotics11030315.

Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic

Affiliations
Review

Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic

Hung-Jen Tang et al. Antibiotics (Basel). .

Abstract

The outbreak of COVID-19 has significantly changed the epidemiology of respiratory tract infection in several ways. The implementation of non-pharmaceutical interventions (NPIs) including universal masking, hand hygiene, and social distancing not only resulted in a decline in reported SARS-CoV-2 cases but also contributed to the decline in the non-COVID-19 respiratory tract infection-related hospital utilization. Moreover, it also led to the decreased incidence of previous commonly encountered respiratory pathogens, such as influenza and Streptococcus pneumoniae. Although antimicrobial agents are essential for treating patients with COVID-19 co-infection, the prescribing of antibiotics was significantly higher than the estimated prevalence of bacterial co-infection, which indicated the overuse of antibiotics or unnecessary antibiotic use during the COVID-19 pandemic. Furthermore, inappropriate antimicrobial exposure may drive the selection of drug-resistant microorganisms, and the disruption of infection control in COVID-19 setting measures may result in the spread of multidrug-resistant organisms (MDROs). In conclusion, NPIs could be effective in preventing respiratory tract infection and changing the microbiologic distribution of respiratory pathogens; however, we should continue with epidemiological surveillance to establish updated information, antimicrobial stewardship programs for appropriate use of antibiotic, and infection control prevention interventions to prevent the spread of MDROs during the COVID-19 pandemic.

Keywords: COVID-19; SARS-CoV-2; antibiotic resistance; non-pharmaceutical intervention; respiratory tract infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The impact of COVID-19 on the epidemiology of respiratory tract infection.

Similar articles

Cited by

References

    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. World Health Organization. [(accessed on 2 February 2022)]. Available online: https://covid19.who.int/
    1. Lai C.C., Chao C.M., Hsueh P.R. Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J. Microbiol. Immunol. Infect. 2021;54:767–775. doi: 10.1016/j.jmii.2021.05.011. - DOI - PMC - PubMed
    1. Sun J., Shi Z., Xu H. Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020. J. Travel Med. 2020;27:taaa064. doi: 10.1093/jtm/taaa064. - DOI - PMC - PubMed
    1. Lai C.C., Yen M.Y., Lee P.I., Hsueh P.R. How to Keep COVID-19 at Bay: A Taiwanese Perspective. J. Epidemiol. Glob. Health. 2021;11:1–5. doi: 10.2991/jegh.k.201028.001. - DOI - PMC - PubMed

LinkOut - more resources